Delivery Order SPE2DB20D7059-SPE2DB25FQAB8
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 vaccine syringes, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The contract has a ceiling value of $20,339.98 and is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen, a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,610.17 firm fixed-price contract is for the delivery of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $9,046.67 and a period of performance ending on June 3, 2024. The contract was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 (0.5 mL syringe) vaccines. The contract has a ceiling value of $64,333.41 and a period of performance through February 4, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The firm-fixed-price contract has a ceiling value of $10,074.63 and is set to expire on July 31, 2024. Amerisourcebergen will be providing the GARDASIL 9 vaccine syringes, which are used to deliver the immunization against certain types of human papillomavirus. This contract is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,979.92 firm-fixed-price contract is for the supply of the GARDASIL 9 vaccine, a pharmaceutical product used to prevent certain types of human papillomavirus infections. This contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,164.69, is for the procurement of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds an Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $3,070.96 and a period of performance through January 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GARDASIL 9 vaccine syringes, with a firm fixed price of $4,997.75 and a completion date of June 12, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The fixed-price contract has a ceiling value of $4,141.27 and a completion date of February 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...